CNBC
US · 4 hrs ago
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.
Do you trust CNBC?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!